The invention is in the field of colloid technology and relates to a process for the production of CS particles and filled microcapsules using porous templates, and to CS particles and microcapsules.
Microcapsules formed of alternately adsorbed poly-electrolyte layers (Layer by Layer, LbL) are known, for example, from [1] and described in DE 198 12 083 A1, DE 199 07 552 A1, EP 0 972 563 A1, WO 99/47252 and U.S. Pat. No. 6,479,146, the disclosure contents of which are hereby completely included. On account of their adjustable semipermeability, such capsule systems have a high application potential as microreactors, drug delivery systems etc. The prerequisite is filling with appropriate active compounds, enzymes, polymers or catalysts.
Furthermore, separating membranes of composite materials which are substance-permeable and coated with polyelectrolyte layers are known from DE 100 31 281 A1.
Hitherto, LbL microcapsules were mainly produced which in the interior contain the same medium (solvent) as outside. In most applications, however, functionalized macromolecules are needed in the interior which should be permanently immobilized and present in dissolved form there in order to maintain their functionality. The known processes for the production of such filled capsules can only be employed under certain conditions. Especially for sensitive biomolecules, difficulties occur with filling according to the known methods.
Hitherto, 4 possibilities for filling with macromolecules have been developed.
It is therefore the object of the present invention to provide a process for encapsulating materials or active compounds in which the active compounds to be encapsulated can be enriched simply and in high concentrations in the interior of the capsules.
According to the invention, this object is achieved by a process for the production of CS particles and/or microparticles having the steps:
As a result, initially CS particles are formed which still contain the porous template as a core containing the adsorbed active compound. Subsequently, the porous template can be dissolved out of the CS particles, microcapsules being formed which are filled with the active compound. Before formation of the capsule shells, at least one primer layer can be applied to the porous templates. If appropriate, further additional layers of polyelectrolytes and/or nanoparticles are applied to the primer layer before the formation of the actual capsule shell. Typically, the capsule shells are prepared by sequential adsorption of alternately charged polyelectrolytes (“LbL process”). Typically, many templates prepared as a colloidal solution are simultaneously coated so that each template is provided with a capsule shell. In consequence, a colloidal solution of CS particles or, after dissolution of the templates, a colloidal solution of microcapsules is obtained, which can optionally be further treated.
In the context of the present invention, porous templates are understood as meaning those particles which have a large number of pores or internal cavities. After the application of the LbL layers and, if appropriate, of a primer layer to the porous templates, core-shell (CS) particles are obtained, which are designated as CS particles. After dissolving out the original porous template, only the shell still exists, i.e. the capsule shell, if appropriate with an internal primer layer, which in the simplest case is filled with the external solvent or with a solution or suspension of the included active compound. These filled shells are designated as capsules or microcapsules. The CS particles or microcapsules are filled with the active compound, i.e. the active compound remains in the CS particles or microcapsules, since the capsule shell acts as a diffusion barrier with respect to the active compound. Colloidal particles which are used for filling the porous particles or for the construction of the LbL shell, and therefore are in general smaller than 100 nm, are designated as nanoparticles.
In contrast to the known methods, the invention described here offers a novel, simple and general method for the encapsulation of materials even in high concentration in CS particles and microcapsules (Layer by Layer polyelectrolyte capsules). LbL CS particles and microcapsules filled with active compounds are produced here with the aid of porous templates. For this, the porous templates are filled with one or more active compounds before LbL coating. If the active compound is only adsorbed inadequately in the pores, special auxiliaries (mediators) or pH changes can be utilized to improve the filling. The filled templates are covered with a special primer which does not penetrate into the pores, but seals it for subsequent coatings. Afterward, the construction of the capsule shell or wall takes place by means of alternating adsorption of polycations and polyanions, whereby a filled CS particle results. For the production of microcapsules, the porous templates can be removed using solvents. Especially in the case of silica particles (SiO2), this can be carried out under mild conditions above pH 4, in order to spare, for example, biological active compounds.
The templates used are porous microparticles whose size is preferably less than 100 μm. The microparticles contain pores having, for example, a pore width of 0.3 nm-100 nm, preferably of 1 nm-30 nm and particularly preferably of 6 nm-10 nm. In many applications, the lower limit of the pore width can be between 1 nm and 6 nm, for example 2 nm or 4 nm, and the upper limit of the pore width can be between 10 nm and 40 nm, for example 15 nm or 30 nm. In principle, the pore width should be so large that the active compounds to be encapsulated penetrate into the pores and can be deposited in the pores, i.e. in particular adsorb in the interior of the pores. Porous templates having a large interior surface are therefore preferred, the interior surface being formed from the inner walls of the pores. In particular, the inner surface effectively available for the adsorption of the active compounds should be large. Effective interior surface is understood here as meaning the part of the surface which is actually available for the adsorption of an active compound of specific size. Since the templates frequently contain pores having different width, large molecular weight active compounds can only penetrate into suitably large pores whereas for smaller molecules the smaller pores are also available. Therefore, the pore size can also be described by means of the size of the nanoparticles or molecules or their molecular weight, which can still penetrate into the pores. The lower limit of the molecular weight is preferably 100 g/mol. The upper limit corresponds to a molecular weight of approximately 5×106 g/mol. In this process, the shape of the penetrating molecule (linear or globular) also plays an important role.
It is furthermore possible for the surface of the pore cavities to be coated by a number of layers of alternately charged polyelectrolytes and/or nanoparticles preferably using the LbL technique, i.e. polyelectrolyte and/or nanoparticle layers are formed on the “interior” surface of the porous templates. The size of the nanoparticles or the molecular weight of the polyelectrolytes is appropriately matched to the pore width. After the dissolution of the templates, a filigree negative impression of the original pore structure of insoluble complexes of polyelectrolyte complexes and/or polyelectrolyte/nanoparticle complexes (interior framework) is obtained which mechanically stabilizes the capsules and greatly increases their interior surface. The active compound to be encapsulated is in this case the material of the interior framework. Additionally, before coating or after the dissolution of the porous template, a further active compound can be intercalated and/or deposited on the interior framework (e.g. by precipitation and/or adsorption), which is then bonded, for example, to the interior framework. In addition to the mechanical stabilization, the advantage of an interior framework is a marked increase in the interior surface of the microcapsules.
Furthermore, the object is achieved by CS particles having
The porous core is the porous templates described. Optionally, between the porous core and the capsule shell can be arranged a primer layer, which surrounds the core and contributes to the improvement of the construction of the capsule shell.
Furthermore, the object is achieved by microcapsules having
In these microcapsules, the porous template or the porous core is removed.
It is further within the scope of the invention to produce microtemplates using the following steps:
The polyelectrolyte and/or nanoparticle layers can optionally be additionally crosslinked (e.g. covalently) before or after the dissolution of the template in order to increase the stability of the microtemplate. In consequence, a filigree framework is again present that corresponds largely to a negative impression of the interior pore structure of the template and here represents the microtemplate. In the coating of the pore surface, it can, of course, also occur that on the outside of the template polyelectrolyte and/or nanoparticle layers are formed which also remain after the dissolution of the template. Depending on the size of the polyelectrolytes and/or nanoparticles used, the shell thus formed is only partly or alternatively to a large extent completely constructed. The microtemplates formed can now be the starting point for the production of further microparticles, e.g. active compounds can be deposited on the framework. The microtemplates are distinguished by a relatively large surface together with a small volume and therefore offer many binding sites for active compounds to be deposited. In comparison to the microcapsules having an interior framework, in the case of the microtemplates no capsule shell having an optional primer layer is formed after the filling of the template with polyelectrolyte and/or nanoparticle layers. The production of the microtemplates and the microcapsules having an internal framework, however, can be carried out using identical materials and under identical conditions. The size of the microtemplates corresponds to the size of the templates used and is therefore in the range indicated above.
The CS particles and/or microcapsules produced and filled with the active compound can be advantageously used in many fields, for example
Further advantageous embodiments of the invention, independently of whether the process, the CS particles or microcapsules are concerned, are described below with the aid of the figures. In these:
The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
The individual process steps are illustrated with the aid of
The active compound can be any material which
The active compounds can be present in molecular form, aggregated, as a complex or in colloidal form. In particular, the active compounds to be encapsulated are polymers and/or proteins and/or organic molecules having molecular weights over 100 g/mol and/or nanoparticles. In particular, they can in this case be enzymes and/or catalysts and/or dyes and/or pharma-ceutical or cosmetic active compounds and/or plant protection agents. The active compounds to be encapsulated can have a different affinity or binding constant with respect to deposition in the pores. The active compounds occupy the available binding sites on the interior surface depending on their binding constants. This different affinity can be utilized in the loading of the templates with a number of active compounds.
Porous templates 2 are colloidal inorganic and organic particles in the size range suitable for LbL capsules between 100 nm and 100 μm, in particular between 500 nm and 15 μm or 30 μm. A distribution of the pore size of these templates 2 which is as small as possible is preferred here, i.e. the pores should preferably largely have the same pore width. In particular, porous colloidal silica particles and/or zeolites and/or organic polymer particles are suitable as templates, since these particles can be produced with a sufficiently narrow distribution of the pore width. Porous zeolite particles in this case have a pore width of, in particular, 0.3 nm to 10 nm.
Filling of the Templates (Step A)
The filling of the porous templates 2 with one or more active compounds 4 can be mediated by attractive interaction, for example take place by adsorption of the active compounds and templates 2 present in a solution (for example an aqueous medium) by means of electrostatic and/or H bonds and/or specific interactions and/or van der Waals interactions. The active compounds used can be organic or inorganic materials, for which Layer by Layer films are impermeable or not very permeable. These materials can be present dissolved, as a solid framework or in colloidal form as nanoparticles. Electrostatic interactions are particularly suitable for the adsorption in the porous templates, since charged materials also form a good exterior surface for the subsequent LbL coating steps. While the filling with molecules which are oppositely charged to the pore or template surface causes no difficulties, materials having an identical charge require special treatment. The three variants mentioned below are in particular suitable therefor:
If a number of active compounds are to be encapsulated, their adsorption can be carried out successively or simultaneously. For filling with the active compounds, pore sizes are used which are related to the size of the molecules to be filled. In particular in the case of silica particles, molecules between 0.1 and 5000 kDa (100 g/mol-5 000 000 g/mol) can be intercalated in pore sizes of 4 to 30 nm. A number of active compounds with comparable binding constants can also be intercalated simultaneously or, in the case of different binding constants, sequentially. Here, the active compound with the higher binding constant is insufficiently filled, i.e. its concentration is chosen such that this active compound does not occupy all available binding sites. Afterward, the incompletely filled particles are filled with the 2nd active compound in a solution by adsorption. In consequence, the templates 4 are largely filled with the active compound(s) 4.
Priming (Step B)
A primer layer 6 of, for example, a polyelectrolyte or of nanoparticles is optionally applied to the now-filled templates 5. The primer material is to be chosen and matched such that it
High molecular weight or/and branched poly-electrolytes and nanoparticles which are matched to the size of the pores are particularly suitable. The primer material 6 typically differs from the materials of the shell to be applied subsequently. If appropriate, it can also be a polyelectrolyte which, however, has a higher molecular weight and/or a more branched structure and/or a better crosslinkage than the LbL capsule shell materials. For this purpose, an extra crosslinking step can be carried out, for example by means of glutaraldehyde in the case of amino-functionalized polyelectrolytes.
Coating (Step C)
Subsequently, alternating layers 8 of cationically and anionically charged substances (polyelectrolytes), preferably polymers, are applied to this primer layer 6 until the desired semi- or impermeability of the LbL capsule wall 9 is achieved for the substance enclosed. The permeability of the LbL capsules can be specifically adjusted here for the particular material encapsulated by means of the layer number, the choice of material, by an aftertreatment by means of annealing, or by implementation of further substances into the capsule wall[8]. After the construction of the capsule wall, CS particles 10 having a filled porous core are present. Suitable substances for the formation of the capsule wall and suitable process courses can be inferred from the already mentioned documents DE 198 12 083 A1, DE 199 07 552 A1, EP 0 972 563 A1, WO 99/47252 and U.S. Pat. No. 6,479,146.
Dissolution of the Cores (Step D)
A subsequent optional dissolution of the cores (templates) out of the CS particles 10 is carried out using a suitable solvent. The products of the dissolution are removed from the capsule interiors by washing with the solvent and water, the filled active compound 4 of greater molecular weight remaining in the interior. In the case of the organic templates, solvents can be organic liquids such as, for example, tetrahydrofuran in the case of polystyrene, or acidic or basic aqueous solutions, such as, for example, HCl in the case of melamine-formaldehyde resins[6]. Silica particles, in particular, can be readily dissolved using 1 mol/l of HF, since the resulting products (SiF62−) readily diffuse outward through the capsule membrane without damaging the capsule wall.[7] 1 molar HF, however, is not unproblematical for many materials.
Therefore, in particular for sensitive active compounds or sensitive capsule wall materials, gentle dissolution of the silica templates at pH values of 3-6.5 is preferred. Here, a fluoride salt having a concentration of 1-5 mol/l is adjusted to a desired pH of 3-6 using a buffer solution of 1-5 mol/l. Porous silica templates, in particular, dissolve in this reaction mixture without residue with sufficient reaction time. The hexafluorosilicate anions also diffuse out of the capsules without problem through thick LbL layers. The preferred pH range extends from 3 or 3.5 (lower limit) up to 6 or 6.5.
The method described for dissolving the templates can be used independently of whether porous or nonporous microparticles are concerned and is suitable, in particular, for dissolving porous and nonporous silica and zeolite particles. This method is moreover suitable in principle for dissolving such materials, these materials being dissolved in the pH range from 3.5 to 6 by fluoride salts in the presence of buffer solution, in particular of an acetate/acetic acid buffer. This dissolution method is particularly suitable for acid-sensitive materials, which either form the capsule wall or are included in the interior. This relates to many biopolymers such as, for example, proteins, enzymes, DNA, but also acid-sensitive polymers or nanoparticles, such as, for example, magnetite or quantum dots (fluorescent nanoparticles).
Optional Release of the Active Compound (Step E)
After the removal of the template, microcapsules 12 (
1. Positively Charged Polymer
10 mg of spherical, porous silica templates having a diameter of 10 μm and a pore size of 7 nm are suspended in 100 μl of water (pH 6.5). 500 μl of a solution of 1 g/l of rhodamine-labeled polyallylamine (PAH-Rho; PAH=poly(allylamine hydrochloride)) having a molecular weight of 70 000 g/mol are added thereto and the mixture is incubated for 12 h. The supernatant is washed away with buffer solution. A solution of fluorescein-labeled chitosan (chitosan-Flu) having a molecular weight of >300 000 g/mol in 0.5 mol/l NaCl is then added to the templates and adsorbed on the surface. As the confocal exposure shows, it forms a homogeneous layer on the surface and barely penetrates into the templates (
The CS particles were incubated with 100 ml of a solution of 2 mol/l of sodium fluoride in 1 mol/l of acetate buffer (pH 4). After 3 h, the templates (cores) have completely dissolved and the capsules filled with PAH remain (
2. Negatively Charged Polymer
10 mg of spherical, porous silica templates having a diameter of 10 μm and a pore size of 7 nm are suspended in 100 μl of water (pH 6.5). Subsequently, the templates are incubated in a 0.1 mol/l solution of FeCl3. After three washing cycles with water, 500 μl of a solution of 1 g/l of rhodamine-labeled polystyrenesulfonate (PSS, MW 130 000 g/mol Capsulation Nanoscience AG) are added and the mixture is incubated for 12 h. The anionically charged PSS-Rho has adsorbed on the surface of the pores via the Fe3+. The PSS supernatant is washed away with water. A solution of chitosan-Flu having a molecular weight of >300 000 g/mol in 0.5 mol/l NaCl is then added to the templates and adsorbed on the surface. After priming, 7 layers of PSS and PAH are applied in an alternating manner using solutions of 1 g/l of polymer in 0.5 mol/l of salt. Between the coating steps, washing with water is carried out 3 times. A concentration of 2.3 g/l of PSS-Rho was then determined in the interior of the CS particles thus obtained (
3. Zwitterionic Protein Albumin
10 mg of spherical, porous silica templates having a diameter of 10 μm and a pore size of 7 nm are suspended in 100 μl of water (pH 6.5). 500 μl of a solution of 1 g/l of rhodamine-labeled bovine serum albumin (TRITC-BSA, Sigma; BSA=bovine serum albumin) in acetate buffer (0.1 M, pH 5) are added thereto and the mixture is incubated for 12 h. The supernatant is washed away with buffer solution, the albumin has markedly accumulated in the interior of the templates. A solution of chitosan-Flu having a molecular weight of >300 000 g/mol in 0.5 mol/l of NaCl is then added to the templates and adsorbed on the surface. After priming, 7 layers of PSS and PAH are applied in an alternating manner using solutions of 1 g/l of polymer in 0.5 mol/l of salt. Between the coating steps, washing with water is carried out 3 times. A concentration of 1.2 g/l of BSA was determined in the interior of the CS particles obtained (
4. Sequential Intercalation of 2 Different Active Compounds
10 mg of spherical, porous silica templates having a diameter of 10 μm and a pore size of 7 nm are suspended in 100 μl of water (pH 6.5). 100 μl of a solution of 1 g/l of polyallylamine (PAH) labeled with rhodamine and having a molecular weight of 70 000 g/mol are added thereto and the mixture is incubated for 12 h. The cationically charged PAH/Rho has accumulated in the interior of the particles. PAH is no longer found in the supernatant. In the next step, a solution of 500 μl of fluorescein-labeled chitosan having a molecular weight of 50 000-300 000 g/mol is added to the particles and the mixture is incubated for a further 12 h. After washing away the chitosan supernatant, a solution of chitosan having a molecular weight of >300 000 g/mol in 0.5 mol/l of NaCl is added to the particles and adsorbed on the surface. After priming, 7 layers of PSS and PAH are applied alternately using solutions of 1 g/l of polymer in 0.5 mol/l of salt. Between the coating steps, washing with water is carried out 3 times. As the confocal exposures show (
5. Filling with Nanoparticles
10 mg of spherical, porous silica templates having a diameter of 10 μm and a pore size of 10 nm are suspended in 100 μl of water (pH 6.5). 100 μl of a solution of 1 g/l of positively charged magnetite nanoparticles having a diameter of 5-10 nm in an acetate buffer solution pH 5.2 are added thereto. After a 12 h incubation, the supernatant is washed away. The porous templates show a marked superparamagnetic activity. A solution of chitosan having a molecular weight of >300 000 g/mol in 0.5 mol/l NaCl is added to the templates and adsorbed on the surface. After priming, 7 layers of PSS and PAH are applied alternately using solutions of 1 g/l of polymer in 0.5 mol/l of salt. Between the coating steps, washing with water is carried out 3 times. After the coating, the magnetic activity has not changed. The silica templates were dissolved out using 100 ml of a solution of 2 mol/l of sodium fluoride in 1 mol/l of acetate buffer pH 4.5. After 12 h, the templates have completely dissolved and the capsules filled with magnetite remain (
a shows confocal images of capsules which are filled with positively charged magnetite nanoparticles and encapsulated using chitosan (PSS/PAH)3PSS (80 μm×80 μm).
6. Microcapsules Having a Solid Structural Framework in the Interior
10 mg of spherical, porous silica templates having a diameter of 10 μm and a pore size of 10 nm are suspended in 100 μl of water (pH 6.5). 100 μl of a solution of 1 g/l of polyallylamine (PAH) labeled with rhodamine and having a molecular weight of 15 000 g/mol in 0.5 mol/l NaCl are added thereto and the mixture is incubated for 60 min with the temporary application of ultrasound. The cationically charged PAH/Rho has accumulated in the interior of the particles. The excess of PAH/Rho is washed away. Afterward, the mixture is incubated with PSS 20 000 g/mol in 0.5 mol/l of salt and the supernatant is washed away. This process is carried out 4 times (8 layers). Afterward, a solution of chitosan having a molecular weight of >300 000 g/mol in 0.5 mol/l of NaCl is added to the particles and adsorbed on the surface. After priming, 7 layers of PSS and PAH 70 000 (labeled with the dye Cy5) are applied alternately using solutions of 1 g/l of polymer in 0.5 mol/l of salt. Between the coating steps, washing with water is carried out. As the confocal exposures show (
List of Reference Symbols
Literature
Number | Date | Country | Kind |
---|---|---|---|
10 2004 013 637 | Mar 2004 | DE | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP2005/002810 | 3/16/2005 | WO | 00 | 6/19/2007 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2005/089727 | 9/29/2005 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3041289 | Katchen et al. | Jun 1962 | A |
3251800 | Colley et al. | May 1966 | A |
3429827 | Ruus | Feb 1969 | A |
3855172 | Iler et al. | Dec 1974 | A |
4001140 | Foris et al. | Jan 1977 | A |
4087376 | Foris et al. | May 1978 | A |
4409331 | Lim | Oct 1983 | A |
4487785 | Goosen et al. | Dec 1984 | A |
4495288 | Jarvis, Jr. et al. | Jan 1985 | A |
4663286 | Tsang et al. | May 1987 | A |
4683092 | Tsang | Jul 1987 | A |
4741872 | De Luca | May 1988 | A |
4835248 | Bader et al. | May 1989 | A |
4940588 | Sparks | Jul 1990 | A |
5091187 | Haynes | Feb 1992 | A |
5162486 | Follmann et al. | Nov 1992 | A |
5308701 | Cohen et al. | May 1994 | A |
5344487 | Whalen-Shaw | Sep 1994 | A |
5427767 | Kresse et al. | Jun 1995 | A |
5487390 | Cohen et al. | Jan 1996 | A |
5512332 | Liberti et al. | Apr 1996 | A |
5674519 | Curtis et al. | Oct 1997 | A |
5705222 | Somasundaran et al. | Jan 1998 | A |
5716709 | Ferguson et al. | Feb 1998 | A |
5756210 | Dupuis et al. | May 1998 | A |
6013284 | De Miquel Ignacia et al. | Jan 2000 | A |
6017559 | Mulqueen et al. | Jan 2000 | A |
6051372 | Bayerl et al. | Apr 2000 | A |
6203909 | Chassot | Mar 2001 | B1 |
6423338 | Larson et al. | Jul 2002 | B1 |
6479146 | Caruso et al. | Nov 2002 | B1 |
6689478 | Laguitton | Feb 2004 | B2 |
6699501 | Neu et al. | Mar 2004 | B1 |
6833192 | Caruso et al. | Dec 2004 | B1 |
7101575 | Donath et al. | Sep 2006 | B2 |
20020039648 | Horpel et al. | Apr 2002 | A1 |
20020172716 | Walt et al. | Nov 2002 | A1 |
20020187197 | Caruso et al. | Dec 2002 | A1 |
20040013728 | Voigt et al. | Jan 2004 | A1 |
20040142341 | Schmitt et al. | Jul 2004 | A1 |
20060251701 | Lynn et al. | Nov 2006 | A1 |
20060275373 | Donath et al. | Dec 2006 | A1 |
20060275374 | Donath et al. | Dec 2006 | A1 |
20060275375 | Donath et al. | Dec 2006 | A1 |
20070020469 | Wood et al. | Jan 2007 | A1 |
Number | Date | Country |
---|---|---|
2012311 | Sep 1990 | CA |
4312970 | Oct 1994 | DE |
19812083 | Sep 1999 | DE |
19907552 | Aug 2000 | DE |
10031281 | Jan 2002 | DE |
10121903 | Oct 2002 | DE |
102004013637 | Mar 2004 | DE |
0127713 | Dec 1984 | EP |
0127989 | Dec 1984 | EP |
0152898 | Aug 1985 | EP |
0188309 | Jul 1986 | EP |
0336014 | Oct 1989 | EP |
0388758 | Sep 1990 | EP |
0392487 | Oct 1990 | EP |
0415273 | Mar 1991 | EP |
0443428 | Aug 1991 | EP |
0472990 | Mar 1992 | EP |
0516252 | Dec 1992 | EP |
540582 | Aug 1994 | EP |
0667148 | Aug 1995 | EP |
0823331 | Feb 1998 | EP |
0972563 | Jan 2000 | EP |
1116516 | Jul 2001 | EP |
1867325 | Dec 2007 | EP |
1183403 | Mar 1970 | GB |
2135954 | Sep 1984 | GB |
2145992 | Apr 1985 | GB |
2153780 | Aug 1985 | GB |
60-190229 | Sep 1985 | JP |
62-213839 | Sep 1987 | JP |
02-001307 | Jan 1990 | JP |
02-290241 | Nov 1990 | JP |
03-137152 | Jun 1992 | JP |
07-213889 | Aug 1995 | JP |
07-251003 | Oct 1995 | JP |
08-169982 | Jul 1996 | JP |
09-012938 | Jan 1997 | JP |
09-077605 | Mar 1997 | JP |
09-208440 | Aug 1997 | JP |
WO 9200998 | Jan 1992 | WO |
WO 9205778 | Apr 1992 | WO |
WO 9526714 | Oct 1995 | WO |
WO 9602136 | Feb 1996 | WO |
WO 9618498 | Jun 1996 | WO |
WO 9630409 | Oct 1996 | WO |
WO 9814180 | Apr 1998 | WO |
WO 9847948 | Oct 1998 | WO |
WO9947252 | Sep 1999 | WO |
WO 0003797 | Jan 2000 | WO |
WO0151196 | Jul 2001 | WO |
WO 0164330 | Sep 2001 | WO |
WO03090920 | Nov 2003 | WO |
WO 2004030648 | Apr 2004 | WO |
WO 2004030649 | Apr 2004 | WO |
2005032512 | Apr 2005 | WO |
WO 2005089825 | Sep 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20080020051 A1 | Jan 2008 | US |